{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:46:53Z","timestamp":1792090013807,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jvir.2013.02.031","type":"journal-article","created":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T08:45:54Z","timestamp":1366361154000},"page":"1227-1234","source":"Crossref","is-referenced-by-count":182,"title":["Yttrium-90 Radioembolization for Intrahepatic Cholangiocarcinoma: Safety, Response, and Survival Analysis"],"prefix":"10.1016","volume":"24","author":[{"given":"Samdeep","family":"Mouli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khairuddin","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Al B.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary F.","family":"Mulcahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2013.02.031_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","article-title":"Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection","volume":"248","author":"Endo","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvir.2013.02.031_bib2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1245\/s10434-009-0777-x","article-title":"Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option","volume":"17","author":"Saxena","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2013.02.031_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.5009\/gnl.2009.3.4.298","article-title":"Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: a large-scale observational study","volume":"3","author":"Park","year":"2009","journal-title":"Gut Liver"},{"key":"10.1016\/j.jvir.2013.02.031_bib4","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1245\/s10434-007-9627-x","article-title":"Surgical management of intrahepatic cholangiocarcinoma\u2014a population-based study","volume":"15","author":"Tan","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2013.02.031_bib5","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvir.2013.02.031_bib6","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/sj.bjc.6603334","article-title":"Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer","volume":"95","author":"Harder","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jvir.2013.02.031_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00280-009-1069-7","article-title":"Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial","volume":"65","author":"Jang","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jvir.2013.02.031_bib8","doi-asserted-by":"crossref","first-page":"W205","DOI":"10.2214\/AJR.10.4937","article-title":"Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma","volume":"196","author":"Kim","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvir.2013.02.031_bib9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00270-010-9849-3","article-title":"Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience","volume":"33","author":"Carrafiello","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2013.02.031_bib10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jvir.2012.01.081","article-title":"Radiofrequency ablation in the management of unresectable intrahepatic cholangiocarcinoma","volume":"23","author":"Fu","year":"2012","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2013.02.031_bib11","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/cncr.25625","article-title":"Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, Ethiodol, and polyvinyl alcohol: a 2-center study","volume":"117","author":"Kiefer","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2013.02.031_bib12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.crad.2010.11.002","article-title":"Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma","volume":"66","author":"Park","year":"2011","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jvir.2013.02.031_bib13","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s11605-007-0282-0","article-title":"Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER Database analysis","volume":"11","author":"Nathan","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jvir.2013.02.031_bib14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0002-9610(91)91111-U","article-title":"Role of radiation after operative palliation in cancer of the proximal bile ducts","volume":"161","author":"Grove","year":"1991","journal-title":"Am J Surg"},{"key":"10.1016\/j.jvir.2013.02.031_bib15","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.23818","article-title":"Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study","volume":"113","author":"Ibrahim","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2013.02.031_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00270-011-0142-x","article-title":"Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival","volume":"35","author":"Hoffmann","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2013.02.031_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.tvir.2007.08.001","article-title":"Technical aspects of radioembolization with 90Y microspheres","volume":"10","author":"Salem","year":"2007","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2013.02.031_bib18","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/annonc\/mdp287","article-title":"Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient\u2019s self-reported questionnaire","volume":"20","author":"Cirillo","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jvir.2013.02.031_bib19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/cncr.24050","article-title":"Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?","volume":"115","author":"Forner","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2013.02.031_bib20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.suc.2010.04.011","article-title":"Intrahepatic cholangiocarcinoma","volume":"90","author":"Poultsides","year":"2010","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.jvir.2013.02.031_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.seminoncol.2010.03.002","article-title":"Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinoma","volume":"37","author":"Hong","year":"2010","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jvir.2013.02.031_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11605-007-0312-y","article-title":"Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience","volume":"12","author":"Gusani","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jvir.2013.02.031_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.RVI.0000143768.60751.78","article-title":"Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution","volume":"16","author":"Burger","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2013.02.031_bib24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00270-008-9336-2","article-title":"Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results","volume":"31","author":"Aliberti","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2013.02.031_bib25","first-page":"3835","article-title":"Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors","volume":"28","author":"Poggi","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jvir.2013.02.031_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2013.02.031_bib27","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1245\/s10434-010-1325-4","article-title":"Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma","volume":"18","author":"Murakami","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2013.02.031_bib28","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archsurg.2012.1962","article-title":"Italian Intrahepatic Cholangiocarcinoma Study Group. Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients","volume":"147","author":"Ribero","year":"2012","journal-title":"Arch Surg"},{"key":"10.1016\/j.jvir.2013.02.031_bib29","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jso.20609","article-title":"Yttrium-90 microspheres (TheraSphere\u00ae) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation","volume":"94","author":"Kulik","year":"2006","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jvir.2013.02.031_bib30","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"Am J Transplant"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044313007197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044313007197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T19:25:24Z","timestamp":1539717924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044313007197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1051044313007197"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2013.02.031","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}